Literature DB >> 17068275

Leishmaniasis.

T V Piscopo1, A C Mallia.   

Abstract

Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity of this infection, and new diagnostic tests that are helping better diagnosis, especially in resource-poor areas. Other important aspects discussed include the potential for newer oral treatment to change the way this disease is managed; leishmania-HIV coinfection and groups at risk; and the development of an effective vaccine.

Entities:  

Mesh:

Year:  2006        PMID: 17068275      PMCID: PMC2653905          DOI: 10.1136/pgmj.2006.047340

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  81 in total

Review 1.  Topical treatment for cutaneous leishmaniasis.

Authors:  Tracy Garnier; Simon L Croft
Journal:  Curr Opin Investig Drugs       Date:  2002-04

2.  Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.

Authors:  I Arevalo; B Ward; R Miller; T C Meng; E Najar; E Alvarez; G Matlashewski; A Llanos-Cuentas
Journal:  Clin Infect Dis       Date:  2001-10-23       Impact factor: 9.079

3.  Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.

Authors:  R Dietze; S F Carvalho; L C Valli; J Berman; T Brewer; W Milhous; J Sanchez; B Schuster; M Grogl
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

4.  Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.

Authors:  S Sundar; G Agrawal; M Rai; M K Makharia; H W Murray
Journal:  BMJ       Date:  2001-08-25

Review 5.  An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine.

Authors:  L Gradoni
Journal:  Vet Parasitol       Date:  2001-09-12       Impact factor: 2.738

6.  Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.

Authors:  Abdulrahman A Alrajhi; Elfaki A Ibrahim; Edward B De Vol; Mohammad Khairat; Rajab M Faris; James H Maguire
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

7.  Leishmania in discarded syringes from intravenous drug users.

Authors:  I Cruz; M A Morales; I Noguer; A Rodríguez; J Alvar
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

8.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

Authors:  N C Hepburn; M J Tidman; J A Hunter
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Nov-Dec       Impact factor: 2.184

10.  Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection.

Authors:  Elizabeth G Rhee; Susana Mendez; Javeed A Shah; Chang-you Wu; Joanna R Kirman; Tara N Turon; Dylan F Davey; Heather Davis; Dennis M Klinman; Rhea N Coler; David L Sacks; Robert A Seder
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  16 in total

Review 1.  Climate change and health research in the Eastern Mediterranean Region.

Authors:  Rima R Habib; Kareem El Zein; Joly Ghanawi
Journal:  Ecohealth       Date:  2010-07-24       Impact factor: 3.184

2.  Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis.

Authors:  Annalisa Celant; Guido Chichino; Barbara Dal Bello; Marco Massarotti; Lorenzo Minoli; Bianca Marasini
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

3.  Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection.

Authors:  Andrés F Flórez; Daeui Park; Jong Bhak; Byoung-Chul Kim; Allan Kuchinsky; John H Morris; Jairo Espinosa; Carlos Muskus
Journal:  BMC Bioinformatics       Date:  2010-09-27       Impact factor: 3.169

4.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

5.  Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.

Authors:  Anila Chacko; Marissa Joseph; Timothy Feltis; Shaun K Morris
Journal:  Am J Trop Med Hyg       Date:  2016-08-22       Impact factor: 2.345

6.  Atypical cutaneous leishmaniasis in the immunosuppressed.

Authors:  Clayton Micallef; Charles Mallia Azzopardi
Journal:  BMJ Case Rep       Date:  2014-06-10

7.  Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63.

Authors:  Irazú Contreras; María Adelaida Gómez; Oliver Nguyen; Marina T Shio; Robert W McMaster; Martin Olivier
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Visceral leishmaniasis with endobronchial involvement in an immunocompetent adult.

Authors:  Konstantinos Kotsifas; Eugenios Metaxas; Ioannis Koutsouvelis; Athanassios Skoutelis; Panayiota Kara; George Tatsis
Journal:  Case Rep Med       Date:  2011-03-10

9.  In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.

Authors:  Negar Seyed; Farnaz Zahedifard; Shima Safaiyan; Elham Gholami; Fatemeh Doustdari; Kayhan Azadmanesh; Maryam Mirzaei; Nasir Saeedi Eslami; Akbar Khadem Sadegh; Ali Eslami Far; Iraj Sharifi; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

10.  Multiple nodular lesions in spleen associated with visceral leishmaniasis: a case report of MRI-findings.

Authors:  Guoqun Mao; Guangzhao Yang; Yougen Cheng; Chi S Zee; Wenmin Huang; Weiyang Ni; Guanmin Meng; Zhilu Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.